-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Xenon Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2024.
- Xenon Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$320K, a 104% decline year-over-year.
- Xenon Pharmaceuticals Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$446K, a 142% decline year-over-year.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was -$292K, a 347% decline from 2022.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $118K.
- Xenon Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was -$6K, a 97.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)